Skip to main content
Premium Trial:

Request an Annual Quote

Xanthon Wins Patent in Australia for Biomolecule Detection Technology

NEW YORK, Oct. 24 - Xanthon has won a patent in Australia that covers a method of directly detecting biomolecules through a “transition-metal-mediated, catalytic, oxidation-reduction reaction,” the company said on Wednesday.

The patent, numbered 724,600 and entitled "Electrochemical detection of nucleic acid hybridization," is owned by the University of North Carolina at Chapel Hill and is exclusively licensed to Xanthon on a worldwide basis.

The patented technology was discovered by Holden Thorp, professor of chemistry at the University of North Carolina at Chapel Hill and co-founder of Xanthon.  

The company, based in Research Triangle Park, NC, is developing a series of analytical platforms based on its proprietary electrochemical technology that it says can make biomolecule detection and information processing more efficient.

Xanthon's first product, the Xpression high-throughput gene-expression analysis system, will be launched to pharmaceutical companies early next year, the company said.

Xanthon also said it is working “under a collaborative agreement” to validate the utility of the its technology “in a diagnostic application where multiple genetic targets are detected in a single sample.” This collaboration may result in a joint product development program.

It was not immediately clear with whom Xanthon has struck this collaboration.

The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.